Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase

被引:192
作者
Bhattacharyya, Sandip
Brown, Diane E.
Brewer, Judson A.
Vogt, Sherri K.
Muglia, Louis J.
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA
关键词
D O I
10.1182/blood-2006-10-048215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To explore the role of glucocorticoids in regulation of kinase pathways during innate immune responses, we generated mice with conditional deletion of glucocorticoid receptor (GR) in macrophages (MGRKO). Activation of toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) caused greater mortality and cytokine production in MGRKO mice than in controls. Ex vivo, treatment with dexamethasone (Dex) markedly inhibited LPS-mediated induction of inflammatory genes in control but not GFI-deficient macrophages. We show that Dex inhibits p38 MAPK, but not PI3K/Akt, ERK or JNK, in control macrophages. Associated with p38 inhibition, Dex induced MAP kinase phosphatase-1 (MKP-1) in control, but not. MGRKO, macrophages. Consistent with the ex vivo studies, treatment with a p38 MAPK-specific inhibitor resulted in rescue of MGRKO mice from LPS-induced lethality. Taken together, we identify p38 MAPK and its downstream targets as essential for GR-mediated Immunosuppression in macrophages.
引用
收藏
页码:4313 / 4319
页数:7
相关论文
共 57 条
[31]   Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways [J].
McKay, LI ;
Cidlowski, JA .
ENDOCRINE REVIEWS, 1999, 20 (04) :435-459
[32]   Innate immunity: The virtues of a nonclonal system of recognition [J].
Medzhitov, R ;
Janeway, CA .
CELL, 1997, 91 (03) :295-298
[33]   Novel inhibitor of p38 MAP kinase as an anti-TNF-α drug:: Discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent [J].
Miwatashi, S ;
Arikawa, Y ;
Kotani, E ;
Miyamoto, M ;
Naruo, K ;
Kimura, H ;
Tanaka, T ;
Asahi, S ;
Ohkawa, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) :5966-5979
[34]   Subnuclear trafficking and gene targeting by steroid receptors [J].
Nagaich, AK ;
Rayasam, GV ;
Martinez, ED ;
Becker, M ;
Qiu, Y ;
Johnson, TA ;
Elbi, C ;
Fletcher, TM ;
John, S ;
Hager, GL .
GLUCOCORTICOID ACTION: BASIC AND CLINICAL IMPLICATIONS, 2004, 1024 :213-220
[35]   Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model [J].
Nash, SP ;
Heuertz, RM .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (13-14) :1870-1880
[36]   Points of control in inflammation [J].
Nathan, C .
NATURE, 2002, 420 (6917) :846-852
[37]   How Toll-like receptors signal: what we know and what we don't know [J].
O'Neill, LAJ .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :3-9
[38]   Molecular determinants of crosstalk between nuclear receptors and toll-like receptors [J].
Ogawa, S ;
Lozach, J ;
Benner, C ;
Pascual, G ;
Tangirala, RK ;
Westin, S ;
Hoffmann, A ;
Subramaniam, S ;
David, M ;
Rosenfeld, MG ;
Glass, CK .
CELL, 2005, 122 (05) :707-721
[39]   Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages [J].
Okugawa, S ;
Ota, Y ;
Kitazawa, T ;
Nakayama, K ;
Yanagimoto, S ;
Tsukada, K ;
Kawada, M ;
Kimura, S .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (02) :C399-C408
[40]   Single-dose pharmacokinetics and pharmacodynamics of RWJ 676579 a specific p38 mitogen-activated protein kinase inhibitor: A first-in-human study [J].
Parasrampuria, DA ;
de Boer, P ;
Desai-Krieger, D ;
Chow, AT ;
Jones, CR .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (04) :406-413